TYVCODO
LIVE

Serial Number

79321251

Owner

Sandoz AG

Filing Date

May 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TYVCODO Trademark

Serial Number: 79321251 • Registration: 6770234

TYVCODO is a trademark filed by Sandoz AG on May 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sandoz AG (9 trademarks)

Viaduktstrasse 3

Entity Type: 03

NOVARTIS AG (7,180 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 11, 2021

Registration Date

June 28, 2022

Published for Opposition

April 12, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 1, 2022 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Oct 12, 2022 FICS
FINAL DISPOSITION PROCESSED
Oct 12, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 28, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 28, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 28, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 23, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2022 CNSA
REFUSAL PROCESSED BY IB
Feb 28, 2022 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 8, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 8, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 8, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 8, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 8, 2022 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 4, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 13, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 12, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 12, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 30, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 30, 2021 REPR